Is the rebound phenomenon serious after stopping taking Apremilast tablets?

Apremilast is considered a relatively mild and long-term tolerable oral immunomodulator in the treatment of plaque psoriasis and psoriatic arthritis. It reduces the levels of pro-inflammatory factors and improves skin plaques and joint symptoms by inhibiting PDE4 enzyme activity. However, many patients worry about a problem during the medication process: Will there be a serious rebound phenomenon once the medication is stopped?

From a mechanism perspective, the role of apremilast is to maintain disease stability by continuously regulating inflammatory pathways, and it does not belong to the "rapid suppression-rapid regression" drug type. Therefore, the disease will not rebound sharply immediately after stopping the drug, but may gradually return to the original disease activity level over time. In other words, a patient's skin damage or joint inflammation may gradually worsen over weeks or months, but a sudden and severe worsening is rare.

However, this does not mean that stopping the medication is completely safe. Psoriasis and psoriatic arthritis themselves are chronic diseases with recurring symptoms. In the absence of long-term drug intervention, skin lesions and joint symptoms may still reappear. In some patients, within a few months after stopping the drug, the area of u200bu200bskin lesions will expand again, and joint stiffness and pain will gradually return, affecting the quality of life. Therefore, clinical experts generally recommend that apremilast should be used as long-term maintenance treatment rather than short-term medication.

It is worth noting that some patients stop taking medication due to financial burden, side effects or personal plans. In this case, they need to communicate with their doctor in advance to formulate a reasonable transition plan. For example, by gradually transitioning to other immunomodulatory drugs or combining topical treatments to reduce the risk of disease exacerbation after drug withdrawal.

In general, serious acute rebound after discontinuation of apremilast usually does not occur, but there is a possibility of gradual relapse of the disease. Whether to discontinue the drug should be decided under the guidance of a doctor based on the stability of the condition, tolerance and life factors.

Reference materials:https://go.drugbank.com/drugs/DB05676